Single nucleotide polymorphisms in the human Aryl Hydrocarbon Receptor Nuclear Translocator (ARNT) Gene

Drug Metabolism and Pharmacokinetics

Volumn 26, Issue 6, 2011, Pages 637-645

  Urban, Jonathan D ^a   Budinsky, Robert A ^b   Rowlands, J Craig ^b  

^a ToxStrategies   (United States)

^b DOW CHEMICAL COMPANY   (United States)

Author keywords

Aryl hydrocarbon receptor nuclear translocator; Dioxin; Ethnicity; Single nucleotide polymorphism

Indexed keywords

ALANINE; HYPOXIA INDUCIBLE FACTOR 1BETA; METHIONINE; THREONINE; VALINE;

ARNT GENE; ARTICLE; COMPUTER MODEL; CONTROLLED STUDY; DNA SEQUENCE; GENE; GENE LOCUS; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PROTEIN DOMAIN; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 84855241733     PISSN: 13474367     EISSN: 18800920     Source Type: Journal    
DOI: 10.2133/dmpk.DMPK-11-SC-031     Document Type: Article

References (39)

1. Boverhof, D. R., Burgoon, L. D., Tashiro, C., Sharratt, B., Chittim, B., Harkema, J. R., Mendrick, D. L. and Zacharewski, T. R.: Comparative toxicogenomic analysis of the hepatotoxic effects of TCDD in Sprague Dawley rats and C57BL/6 mice. Toxicol. Sci., 94: 398-416 2006.
2. Tijet, N., Boutros, P. C., Moffat, I. D., Okey, A. B., Tuomisto, J. and Pohjanvirta, R.: Aryl hydrocarbon receptor regulates distinct dioxin-dependent and dioxin-independent gene batteries. Mol. Pharmacol., 69: 140-153 2006.
3. Kim, S., Dere, E., Burgoon, L. D., Chang, C. C. and Zacharewski, T. R.: Comparative analysis of AhR-mediated TCDD-elicited gene expression in human liver adult stem cells. Toxicol. Sci., 112: 229-244 2009.
4. Moffat, I. D., Boutros, P. C., Chen, H., Okey, A. B. and Pohjanvirta, R.: Aryl hydrocarbon receptor AHR-regulated transcriptomic changes in rats sensitive or resistant to major dioxin toxicities. BMC Genomics, 11: 263-278 2010.
5. Rowlands, J. C. and Gustafsson, J. A.: Aryl hydrocarbon receptor- mediated signal transduction. Crit. Rev. Toxicol., 27: 109-134 1997.
6. Walisser, J. A., Bunger, M. K., Glover, E. and Bradfield, C. A.: Gestational exposure of Ahr and Arnt hypomorphs to dioxin rescues vascular development. Proc. Natl. Acad. Sci. USA, 101: 16677-16682 2004.
7. Wilson, C. L. and Safe, S.: Mechanisms of ligand-induced aryl hydrocarbon receptor-mediated biochemical and toxic responses. Toxicol. Pathol., 26: 657-671 1998.
8. Lando, D., Gorman, J. J., Whitelaw, M. L. and Peet, D. J.: Oxygen-dependent regulation of hypoxia-inducible factors by prolyl and asparaginyl hydroxylation. Eur. J. Biochem., 270: 781-790 2003.
9. Kozak, K. R., Abbott, B. and Hankinson, O.: ARNT-deficient mice and placental differentiation. Dev. Biol., 191: 297-305 1997.
10. Maltepe, E., Schmidt, J. V., Baunoch, D., Bradfield, C. A. and Simon, M. C.: Abnormal angiogenesis and responses to glucose and oxygen deprivation in mice lacking the protein ARNT. Nature, 386: 403-407 1997.
11. Gunton, J. E., Kulkarni, R. N., Yim, S., Okada, T., Hawthorne, W. J., Tseng, Y. H., Roberson, R. S., Ricordi, C., OöConnell, P. J., Gonzalez, F. J. and Kahn, C. R.: Loss of ARNT/HIF1beta mediates altered gene expression and pancreatic-islet dysfunction in human type 2 diabetes. Cell, 122: 337-349 2005.
12. Figueroa, J. D., Malats, N., Garcia-Closas, M., Real, F. X., Silverman, D., Kogevinas, M., Chanock, S., Welch, R., Dosemeci, M., Lan, Q., Tardon, A., Serra, C., Carrato, A., Garcia-Closas, R., Castano-Vinyals, G. and Rothman, N.: Bladder cancer risk and genetic variation in AKR1C3 and other metabolizing genes. Carcinogenesis, 29: 1955-1962 2008.
13. Guo, S. W.: The association of endometriosis risk and genetic polymorphisms involving dioxin detoxification enzymes: a system- atic review. Eur. J. Obstet. Gynecol. Reprod. Biol., 124: 134-143 2006.
14. Watanabe, T., Imoto, I., Kosugi, Y., Fukuda, Y., Mimura, J., Fujii, Y., Isaka, K., Takayama, M., Sato, A. and Inazawa, J.: Human arylhydrocarbon receptor repressor {currency sign}AHRR gene: genomic structure and analysis of polymorphism in endometriosis. J. Hum. Genet., 46: 342-346 2001.
15. Wang, H., Yamamoto, J. F., Caberto, C., Saltzman, B., Decker, R., Vogt, T. M., Yokochi, L., Chanock, S., Wilkens, L. R. and Le Marchand, L.: Genetic variation in the bioactivation pathway for polycyclic hydrocarbons and heterocyclic amines in relation to risk of colorectal neoplasia. Carcinogenesis, 32: 203-209 2011.
16. Hahn, M. E., Karchner, S. I., Franks, D. G. and Merson, R. R.: Aryl hydrocarbon receptor polymorphisms and dioxin resistance in Atlantic killifish {currency sign}Fundulus heteroclitus. Pharmacogenetics, 14: 131-143 2004.
17. Micka, J., Milatovich, A., Menon, A., Grabowski, G. A., Puga, A. and Nebert, D. W.: Human Ah receptor {currency sign}AHR gene: localization to 7p15 and suggestive correlation of polymorphism with CYP1A1 inducibility. Pharmacogenetics, 7: 95-101 1997.
18. Poland, A., Palen, D. and Glover, E.: Analysis of the four alleles of the murine aryl hydrocarbon receptor. Mol. Pharmacol., 46: 915-921 1994.
19. Celius, T. and Matthews, J.: Functional analysis of six human aryl hydrocarbon receptor variants in human breast cancer and mouse hepatoma cell lines. Toxicology, 277: 59-65 2010.
20. Rowlands, J. C., Staskal, D. F., Gollapudi, B. and Budinsky, R.: The human AHR: identification of single nucleotide polymorphisms from six ethnic populations. Pharmacogenet. Genomics, 20: 283-290 2010.
21. Rowlands, J. C., Urban, J. D., Staskal Wikoff, D. and Budinsky, R. A.: An evaluation of single nucleotide polymorphisms in the human aryl hydrocarbon receptor-interacting protein AIP gene. Drug Metab. Pharmacokinet., 26: 431-439 2011.
22. Korkalainen, M., Tuomisto, J. and Pohjanvirta, R.: Identification of novel splice variants of ARNT and ARNT2 in the rat. Biochem. Biophys. Res. Commun., 303: 1095-1100 2003.
23. Coassin, S., Brandstatter, A. and Kronenberg, F.: Lost in the space of bioinformatic tools: a constantly updated survival guide for genetic epidemiology. The GenEpi Toolbox. Atherosclerosis, 209: 321-335 2010.
24. Desmet, F. O., Hamroun, D., Lalande, M., Collod-Beroud, G., Claustres, M. and Beroud, C.: Human Splicing Finder: an online bioinformatics tool to predict splicing signals. Nucleic Acids Res., 37: 1-14 2009.
25. Yuan, H. Y., Chiou, J. J., Tseng, W. H., Liu, C. H., Liu, C. K., Lin, Y. J., Wang, H. H., Yao, A., Chen, Y. T. and Hsu, C. N.: FASTSNP: an always up-to-date and extendable service for SNP function analysis and prioritization. Nucleic Acids Res., 34: W635-W641 2006.
26. Liu, C. K., Chen, Y. H., Tang, C. Y., Chang, S. C., Lin, Y. J., Tsai, M. F., Chen, Y. T. and Yao, A.: Functional analysis of novel SNPs and mutations in human and mouse genomes. BMC Bioinformatics, 9 Suppl. 12: S10-S16 2008.
27. Evans, M. R., Card, P. B. and Gardner, K. H.: ARNT PAS-B has a fragile native state structure with an alternative beta-sheet register nearby in sequence space. Proc. Natl. Acad. Sci. USA, 106: 2617-2622 2009.
28. Ng, P. C. and Henikoff, S.: Predicting the effects of amino acid substitutions on protein function. Annu. Rev. Genomics Hum. Genet., 7: 61-80 2006.
29. Kuick, R. D., Neel, J. V., Strahler, J. R., Chu, E. H., Bargal, R., Fox, D. A. and Hanash, S. M.: Similarity of spontaneous germinal and in vitro somatic cell mutation rates in humans: implications for carcinogenesis and for the role of exogenous factors in úspontaneousû germinal mutagenesis. title typejournalProc. Natl. Acad. Sci/title. misctextUSA/misctext, vol89/vol: page typefirst7036/pagex-/xpage typelast7040/page 1992.
30. Mohyuddin, A., Ayub, Q., Siddiqi, S., Carvalho-Silva, D. R., Mazhar, K., Rehman, S., Firasat, S., Dar, A., Tyler-Smith, C. and Mehdi, S. Q.: Genetic instability in EBV-transformed lympho- blastoid cell lines. Biochim. Biophys. Acta, 1670: 81-83 2004.
31. Taylor, B. L. and Zhulin, I. B.: PAS domains: internal sensors of oxygen, redox potential, and light. Microbiol. Mol. Biol. Rev., 63: 479-506 1999.
32. Chapman-Smith, A., Lutwyche, J. K. and Whitelaw, M. L.: Contribution of the Per/Arnt/Sim {currency sign}PAS domains to DNA binding by the basic helix-loop-helix PAS transcriptional regulators. J. Biol. Chem., 279: 5353-5362 2004.
33. Paulussen, A., Raes, A., Matthijs, G., Snyders, D. J., Cohen, N. and Aerssens, J.: A novel mutation T65P in the PAS domain of the human potassium channel HERG results in the long QT syndrome by trafficking deficiency. J. Biol. Chem., 277: 48610-48616 2002.
34. Numayama-Tsuruta, K., Kobayashi, A., Sogawa, K. and Fujii-Kuriyama, Y.: A point mutation responsible for defective function of the aryl-hydrocarbon-receptor nuclear translocator in mutant Hepa-1c1c7 cells. Eur. J. Biochem., 246: 486-495 1997.
35. George Priya Doss, C. and Sethumadhavan, R.: Computational and structural analysis of deleterious functional SNPs in ARNT oncogene. Interdiscip. Sci., 1: 220-228 2009.
36. Scheel, J., Hussong, R., Schrenk, D. and Schmitz, H. J.: Variability of the human aryl hydrocarbon receptor nuclear translocator ARNT gene. J. Hum. Genet., 47: 217-224 2002.
37. Cao, H. and Hegele, R. A.: Human aryl hydrocarbon receptor nuclear translocator gene ARNT D/N511 polymorphism. J. Hum. Genet., 45: 92-93 2000.
38. Anttila, S., Lei, X. D., Elovaara, E., Karjalainen, A., Sun, W., Vainio, H. and Hankinson, O.: An uncommon phenotype of poor inducibility of CYP1A1 in human lung is not ascribable to polymorphisms in the AHR, ARNT, or CYP1A1 genes. Pharmacogenetics, 10: 741-751 2000.
39. Das, S. K., Sharma, N. K., Chu, W. S., Wang, H. and Elbein, S. C.: Aryl hydrocarbon receptor nuclear translocator {currency sign}ARNT gene as a positional and functional candidate for type 2 diabetes and prediabetic intermediate traits: Mutation detection, case-control studies, and gene expression analysis. BMC Med. Genet., 9: 16-27 2008.